Table M.7Cost effectiveness of screening strategies in 60 000 pregnant women with mild or moderate gestational hypertension

StudyICER (mild)ICER (moderate)
Leanos-Miranda et al., 200791PCR dominatesPCR dominates
Ramos et al., 199992Auto + 24-hour: £967 per QALYAuto + 24-hour: £1,742 per QALY
Wheeler et al., 200793Auto + 24-hour: £967 per QALYAuto + 24-hour: £1,742 per QALY
Al et al., 200494Auto + 24-hour dominatesAuto + 24-hour dominates
Dwyer et al., 200890Auto + 24-hour dominatesAuto + 24-hour dominates

ICER = incremental cost-effectiveness ratio; QALY = quality-adjusted life year

From: Appendix M, Cost effectiveness of quantifying proteinuria in women with gestational hypertension

Cover of Hypertension in Pregnancy
Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy.
NICE Clinical Guidelines, No. 107.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2010 Aug.
Copyright © 2011, Royal College of Obstetricians and Gynaecologists.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.